Max Healthcare Institute · NSE: MAXHEALTH · BSE: 543220
Q3 FY25 results · Oct–Dec 2024
Max Healthcare Institute reported revenue from operations of ₹1,868.31 crore (up 40.0% from Q3 FY24) and net profit of ₹238.80 crore (down 17.5% from Q3 FY24) for Q3 FY25 (Oct–Dec 2024), on a consolidated basis.
| Item | Q3 FY25 | Q3 FY24 | YoY | Q2 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,868.31 | 1,334.97 | +40.0% | 1,707.46 | +9.4% |
| Other income | 33.30 | 46.02 | −27.6% | 40.84 | −18.5% |
| Total income | 1,901.61 | 1,380.99 | +37.7% | 1,748.30 | +8.8% |
| Profit before tax | 308.87 | 359.68 | −14.1% | 373.69 | −17.3% |
| Net profit for the period | 238.80 | 289.34 | −17.5% | 281.81 | −15.3% |
| EPS, basic (₹) | 2.46 | 2.98 | −17.4% | 2.90 | −15.2% |
| Net margin (%) | 12.8 | 21.7 | 16.5 |
| Item | Q3 FY25 | Q3 FY24 | YoY | Q2 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 697.40 | 590.75 | +18.1% | 686.11 | +1.6% |
| Other income | 92.01 | 42.68 | +115.6% | 133.51 | −31.1% |
| Total income | 789.41 | 633.43 | +24.6% | 819.62 | −3.7% |
| Profit before tax | 198.18 | 203.33 | −2.5% | 318.15 | −37.7% |
| Net profit for the period | 138.24 | 158.12 | −12.6% | 231.30 | −40.2% |
| EPS, basic (₹) | 1.42 | 1.63 | −12.9% | 2.38 | −40.3% |
| Net margin (%) | 19.8 | 26.8 | 33.7 |
Consolidated
- Filed with BSE
- 30 Jan 2025, 15:02 IST
- Board meeting
- 30 Jan 2025
- Period
- 01 Oct 2024 to 31 Dec 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 30 Jan 2025, 15:02 IST
- Board meeting
- 30 Jan 2025
- Period
- 01 Oct 2024 to 31 Dec 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE